Targeting integrins alpha v beta 3 and alpha v beta 5 for blocking tumor-induced angiogenesis.
Kumar
C C
CC
Schering-Plough Research Institute, Kenilworth, NJ 07033, USA.
Armstrong
L
L
Yin
Z
Z
Malkowski
M
M
Maxwell
E
E
Ling
H
H
Yaremko
B
B
Liu
M
M
Varner
J
J
Smith
E M
EM
Neustadt
B
B
Nechuta
T
T
D000818:Animals; D006801:Humans; D016023:Integrins / Q000378:metabolism / Q000502:physiology*; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D009389:Neovascularization, Pathologic / Q000378:metabolism*; D019030:Receptors, Vitronectin / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*
D016023:Integrins; D019030:Receptors, Vitronectin; C064660:integrin alphaVbeta5